Alpha Tau Medical Ltd. (DRTS) |
|
9.205 -1.415 (-13.32%)
|
08-18 07:28 |
|
Open: |
10.25 |
Pre. Close: |
10.62 |
|
High:
|
10.5 |
Low:
|
9.0021 |
|
Volume:
|
39,582 |
Market Cap:
|
630(M) |
|
|
|
|
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
10.51 - 10.58 |
10.58 - 10.62 |
|
Low:
|
8.86 - 8.94 |
8.94 - 8.99 |
|
Close:
|
9.11 - 9.22 |
9.22 - 9.29 |
|
Technical analysis |
as of: 2022-08-17 4:22:45 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 12.28 One year: 13.37 |
| Support: |
Support1: 9 Support2: 7.48 |
| Resistance: |
Resistance1: 10.51 Resistance2: 11.44 |
| Pivot: |
10.59 |
| Moving Average: |
MA(5): 10.34 MA(20): 10.62
MA(100): 9.55 MA(250): 9.9 |
| MACD: |
MACD(12,26): -0.1 Signal(9): 0.1 |
| Stochastic oscillator: |
%K(14,3): 25.8 %D(3): 27.7 |
| RSI: |
RSI(14): 35.5 |
| 52-week: |
High: 20.64 Low: 4.68 |
| Average Vol(K): |
3-Month: 104 (K) 10-Days: 19 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ DRTS ] has closed below the lower bollinger band by 33.2%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ DRTS ] is to continue within current trading range. It is unclear right now based on current values. 60.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 18 Aug 2022
DRT Strategies CEO James Gordon Presented 1st Wash100 Award By Executive Mosaic CEO Jim Garrettson - GovCon Wire
Wed, 17 Aug 2022
DRT chapter hosts Texas essay contest - Fredericksburg Standard
Tue, 16 Aug 2022
FCT moves resuscitates Abuja urban mass transport company – The Sun Nigeria - Daily Sun
Mon, 15 Aug 2022
Insiders might want to re-evaluate their US$724k stock purchase as DIRTT Environmental Solutions Ltd. (TSE:DRT) drops to CA$78m - Yahoo Finance
Fri, 12 Aug 2022
All aboard! How on‑demand public transport is getting back on the road - The Guardian
Thu, 11 Aug 2022
Alpha Tau Medical (NASDAQ:DRTS) Trading 0.4% Higher - Defense World
|
Financial Analysis |
| Price to Book Value: |
Neutral |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Neutral |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
68 (M) |
| Shares Float |
38 (M) |
|
% Held by Insiders
|
34.6 (%) |
|
% Held by Institutions
|
3.9 (%) |
|
Shares Short
|
262 (K) |
|
Shares Short P.Month
|
201 (K) |
Stock Financials |
|
EPS
|
-0.99 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.39 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
0 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
-57.1 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0 |
|
Sales Per Share
|
0 |
|
EBITDA (p.s.)
|
-0.28 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-15 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-9.4 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
6.57 |
|
Price to Sales
|
0 |
|
Price to Cash Flow
|
-41.29 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
